USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Boehringer Ingelheim International Gmbh

USPTO PatentsView assignee record - 662 granted patents across 61 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

662

Total patents granted

CPC technology areas

17.1

Avg claims per patent

-35%

5-year filing velocity

The verdict

Boehringer holds 662 US patents across 61 technology areas, rank #678 of 50,000 tracked assignees.

#678
of 50,000 US assignees by volume: Top 2%
by Innovation Score (63.6/100): 17.1
avg claims per patent: -35%
filing velocity, last 5 yrs

Portfolio overview

Boehringer Ingelheim International Gmbh has been granted 662 US utility patents between 2015 and 2025, placing Boehringer Ingelheim International Gmbh at rank #678 across all assignees tracked by PlainPatent. This portfolio spans 61 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.1 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Boehringer Ingelheim International Gmbh is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Boehringer sits between Socionext Inc. (668 patents, rank #674) and Pfizer Inc. (659 patents, rank #682) - the closest US assignees by grant volume. The composite Innovation Score of 63.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 260 grants, compared with 402 in the 2015–2019 window, a -35% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Boehringer Ingelheim International Gmbh's 17.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 61 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Boehringer Ingelheim International Gmbh against peers pursuing similar technology classes.

Socionext

668
Takeda Pharmaceut…

668
thyssenkrupp

665
Groupon

664
Boehringer Ingelh… ◀

662
Datang Mobile Com…

661
Ordos Yuansheng O…

661
Accenture Global…

660
Pfizer

659

What this shows Boehringer holds 662 patents at rank #678, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Boehringer

By rank, the assignees closest to #678 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Boehringer's primary technology class.

Boehringer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

64 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Boehringer Ingelheim International Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	148	22.4%
2016	85	12.8%
2017	53	8.0%
2018	61	9.2%
2019	55	8.3%
2020	48	7.3%
2021	45	6.8%
2022	35	5.3%
2023	41	6.2%
2024	55	8.3%
2025	36	5.4%

Which technologies does Boehringer Ingelheim International Gmbh patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 468

C07D - HETEROCYCLIC COMPOUNDS 359

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 324

C07K - PEPTIDES 101

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 73

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 48

B05B - SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES 42

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 32

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 25

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 23

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 21

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 19

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 19

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 16

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 12

Top 15 of 61 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#678

Across all tracked assignees

Innovation Score

63.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Boehringer Ingelheim International Gmbh hold?

Boehringer Ingelheim International Gmbh holds 662 US granted patents filed between 2015 and 2025, spanning 61 technology areas.

What is Boehringer Ingelheim International Gmbh's Innovation Score?

Boehringer Ingelheim International Gmbh has an Innovation Score of 63.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Boehringer Ingelheim International Gmbh focus on?

Boehringer Ingelheim International Gmbh's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 468 patents. The company has filed patents in 61 CPC subclasses total.

Is Boehringer Ingelheim International Gmbh's patent filing rate increasing or decreasing?

Boehringer Ingelheim International Gmbh's recent filing velocity is -35% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Boehringer Ingelheim International Gmbh's patents?

Boehringer Ingelheim International Gmbh's patents average 17.1 claims each. This falls within the standard range, providing solid legal coverage.

How is the Boehringer Ingelheim International Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Boehringer's 662 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Boehringer ranks #678 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.